STC2 is a potential biomarker of hepatocellular carcinoma with its expression being upregulated in Nrf1α-deficient cells, but downregulated in Nrf2-deficient cells

Anwanwan, 2020, Challenges in liver cancer and possible treatment approaches, Biochim. Biophys. Acta Rev. Cancer, 1873, 10.1016/j.bbcan.2019.188314 Marengo, 2016, Liver cancer: connections with obesity, fatty liver, and cirrhosis, Annu. Rev. Med., 67, 103, 10.1146/annurev-med-090514-013832 Sheka, 2020, Nonalcoholic steatohepatitis: a review, Jama, 323, 1175, 10.1001/jama.2020.2298 Huang, 2021, Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention, 18, 223 Raza, 2021, Current treatment paradigms and emerging therapies for NAFLD/NASH, Front. Biosci. (Landmark Ed.), 26, 206, 10.2741/4892 Foerster, 2022, NAFLD-driven HCC: safety and efficacy of current and emerging treatment options, J. Hepatol., 76, 446, 10.1016/j.jhep.2021.09.007 Xu, 2005, Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia, Proc. Natl. Acad. Sci. U. S. A., 102, 4120, 10.1073/pnas.0500660102 Cui, 2017, Deficiency of long isoforms of Nfe2l1 sensitizes MIN6 pancreatic β cells to arsenite-induced cytotoxicity, Toxicol. Appl. Pharmacol., 329, 67, 10.1016/j.taap.2017.05.013 Zhang, 2016, Molecular and cellular basis for the unique functioning of Nrf1, an indispensable transcription factor for maintaining cell homoeostasis and organ integrity, Biochem. J., 473, 961, 10.1042/BJ20151182 Chan, 1998, Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice, EMBO J., 17, 1779, 10.1093/emboj/17.6.1779 Chan, 1996, NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development, Proc. Natl. Acad. Sci. U. S. A., 93, 13943, 10.1073/pnas.93.24.13943 Hirotsu, 2012, NF-E2-related factor 1 (Nrf1) serves as a novel regulator of hepatic lipid metabolism through regulation of the Lipin1 and PGC-1β genes, Mol. Cell. Biol., 32, 2760, 10.1128/MCB.06706-11 Katsuoka, 2016, Small Maf deficiency recapitulates the liver phenotypes of Nrf1- and Nrf2-deficient mice, Genes Cells, 21, 1309, 10.1111/gtc.12445 Qiu, 2018, Oncogenic activation of Nrf2, though as a master antioxidant transcription factor, liberated by specific knockout of the full-length Nrf1α that acts as a dominant tumor repressor, 10 Na, 2015, Stanniocalcin-2 (STC2): a potential lung cancer biomarker promotes lung cancer metastasis and progression, Biochim. Biophys. Acta, 1854, 668, 10.1016/j.bbapap.2014.11.002 Kita, 2011, STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma, Ann. Surg. Oncol., 18, 261, 10.1245/s10434-010-1271-1 Tamura, 2009, Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer, Cancer Sci., 100, 914, 10.1111/j.1349-7006.2009.01117.x Wang, 2012, STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro, BMB Rep., 45, 629, 10.5483/BMBRep.2012.45.11.086 Yokobori, 2010, Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer, Ann. Surg. Oncol., 17, 2601, 10.1245/s10434-010-1086-0 Wang, 2013, Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer, World J. Surg. Oncol., 11, 81, 10.1186/1477-7819-11-81 Lin, 2019, STC2 is a potential prognostic biomarker for pancreatic cancer and promotes migration and invasion by inducing epithelial-mesenchymal, Transition, 2019, 8042489 Ito, 2004, Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties, Mol. Cell. Biol., 24, 9456, 10.1128/MCB.24.21.9456-9469.2004 Leonard, 2003, The role of HIF-1 alpha in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia, J. Biol. Chem., 278, 40296, 10.1074/jbc.M302560200 Law, 2008, Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells, Exp. Cell Res., 314, 1823, 10.1016/j.yexcr.2008.03.001 Law, 2010, Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells, Exp. Cell Res., 316, 3425, 10.1016/j.yexcr.2010.06.026 Law, 2010, Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia, Exp. Cell Res., 316, 466, 10.1016/j.yexcr.2009.09.018 Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol., 15, 550, 10.1186/s13059-014-0550-8 Ren, 2016, TALENs-directed knockout of the full-length transcription factor Nrf1a that represses malignant behaviour of human hepatocellular carcinoma (HepG2) cells, Sci. Rep., 7 Zhang, 2010, Identification of topological determinants in the N-terminal domain of transcription factor Nrf1 that control its orientation in the endoplasmic reticulum membrane, Biochem. J., 430, 497, 10.1042/BJ20100471 Morton, 2007, Establishment of human tumor xenografts in immunodeficient mice, Nat. Protoc., 2, 247, 10.1038/nprot.2007.25 Kim, 2015, HISAT: a fast spliced aligner with low memory requirements, 12, 357 Langmead, 2012, Fast gapped-read alignment with Bowtie 2, Nat. Methods, 9, 357, 10.1038/nmeth.1923 Zeiger, 2011, Stanniocalcin 2 is a negative modulator of store-operated calcium entry, Mol. Cell. Biol., 31, 3710, 10.1128/MCB.05140-11 2019, The Gene Ontology Resource: 20 years and still GOing strong, Nucleic Acids Res., 47, D330, 10.1093/nar/gky1055 Kanehisa, 2000, KEGG: Kyoto encyclopedia of genes and genomes, Nucleic Acids Res., 28, 27, 10.1093/nar/28.1.27 Chandrashekar, 2017, UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses, Neoplasia, 19, 649, 10.1016/j.neo.2017.05.002 Menyhárt, 2018, Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma, 5 Tang, 2017, GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses, Nucleic Acids Res., 45, W98, 10.1093/nar/gkx247 Kim, 2015, Stanniocalcin 2 enhances mesenchymal stem cell survival by suppressing oxidative stress, BMB Rep., 48, 702, 10.5483/BMBRep.2015.48.12.158 Harper, 2013, Identification of stanniocalcin 2 as a novel aryl hydrocarbon receptor target gene, J. Pharmacol. Exp. Ther., 344, 579, 10.1124/jpet.112.201111 Vengellur, 2004, The role of hypoxia inducible factor 1alpha in cobalt chloride induced cell death in mouse embryonic fibroblasts, Toxicol. Sci., 82, 638, 10.1093/toxsci/kfh278 Zhang, 2017, Cobalt chloride-induced hypoxia induces epithelial-mesenchymal transition in renal carcinoma cell lines, Ann. Clin. Lab. Sci., 47, 40 Wang, 2021, TCF11 has a potent tumor-repressing effect than its prototypic Nrf1α by definition of both similar yet different regulatory profiles, with a striking disparity from Nrf2, Front. Oncol., 11 Jaskulska, 2020, Thapsigargin-from traditional medicine to anticancer drug, 22, 1 Ao, 2008, Cancer as robust intrinsic state of endogenous molecular-cellular network shaped by evolution, Med. Hypotheses, 70, 678, 10.1016/j.mehy.2007.03.043 Yuan, 2017, Cancer as robust intrinsic state shaped by evolution: a key issues review, Rep. Prog. Phys., 80, 10.1088/1361-6633/aa538e Wang, 2018, Endogenous molecular-cellular network cancer theory: a systems biology approach, Methods Mol. Biol., 1702, 215, 10.1007/978-1-4939-7456-6_11 Wang, 2014, Quantitative implementation of the endogenous molecular-cellular network hypothesis in hepatocellular carcinoma, Interface Focus, 4, 20130064, 10.1098/rsfs.2013.0064 Meyer, 2009, Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma, Eur. Urol., 55, 669, 10.1016/j.eururo.2008.04.001 Zhang, 2019, Upregulation of STC2 in colorectal cancer and its clinicopathological significance, Onco. Targets Ther., 12, 1249, 10.2147/OTT.S191609 Arigami, 2013, Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer, Oncol. Rep., 30, 2838, 10.3892/or.2013.2775 Fang, 2014, Clinical significance of stanniocalcin expression in tissue and serum of gastric cancer patients, Chin. J. Cancer Res., 26, 602 Lin, 2014, Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas, J. Exp. Clin. Cancer Res., 33, 26, 10.1186/1756-9966-33-26 Clapham, 2007, Calcium signaling, Cell, 131, 1047, 10.1016/j.cell.2007.11.028 Infantino, 2021, Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target, Int. J. Mol. Sci., 22, 10.3390/ijms22115703 Baird, 2020, The molecular mechanisms regulating the KEAP1-NRF2 pathway, Mol. Cell. Biol., 40, 10.1128/MCB.00099-20 Xiang, 2018, Mechanisms controlling the multistage post-translational processing of endogenous Nrf1alpha/TCF11 proteins to yield distinct isoforms within the coupled positive and negative feedback circuits, Toxicol. Appl. Pharmacol., 360, 212, 10.1016/j.taap.2018.09.036 Chen, 2003, Nrf1 is critical for redox balance and survival of liver cells during development, Mol. Cell. Biol., 23, 4673, 10.1128/MCB.23.13.4673-4686.2003 Gao, 2007, HIF-dependent antitumorigenic effect of antioxidants in vivo, Cancer Cell, 12, 230, 10.1016/j.ccr.2007.08.004 Lee, 2009, Oltipraz and dithiolethione congeners inhibit hypoxia-inducible factor-1alpha activity through p70 ribosomal S6 kinase-1 inhibition and H2O2-scavenging effect, Mol. Cancer Ther., 8, 2791, 10.1158/1535-7163.MCT-09-0420 Eba, 2013, The nuclear factor erythroid 2-related factor 2 activator oltipraz attenuates chronic hypoxia-induced cardiopulmonary alterations in mice, Am. J. Respir. Cell Mol. Biol., 49, 324, 10.1165/rcmb.2011-0396OC Lv, 2020, Mesenchymal stromal cells ameliorate acute lung injury induced by LPS mainly through stanniocalcin-2 mediating macrophage polarization, Ann. Transl. Med., 8, 334, 10.21037/atm.2020.02.105 Wu, 2014, Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis, Genes Dev., 28, 708, 10.1101/gad.238246.114 Chowdhry, 2013, Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity, Oncogene, 32, 3765, 10.1038/onc.2012.388 Rada, 2011, SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner, Mol. Cell. Biol., 31, 1121, 10.1128/MCB.01204-10 Zhang, 2015, Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma, BMC Cancer, 15, 531, 10.1186/s12885-015-1541-1 Raghunath, 2018, Dysregulation of Nrf2 in hepatocellular carcinoma: role in cancer progression and chemoresistance, Cancers (Basel), 10, 10.3390/cancers10120481 Lake, 2014, The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease, Toxicol. Sci., 137, 26, 10.1093/toxsci/kft230 Ohtsuji, 2008, Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes, J. Biol. Chem., 283, 33554, 10.1074/jbc.M804597200 Sarapio, 2019, Stanniocalcin-1 and -2 effects on glucose and lipid metabolism in white adipose tissue from fed and fasted rats, Can. J. Physiol. Pharmacol., 97, 916, 10.1139/cjpp-2019-0023